Literature DB >> 1561190

Erythromelalgia--the role of hypnotherapy.

K Chakravarty1, P D Pharoah, D G Scott, S Barker.   

Abstract

Erythromelalgia is an unusual condition characterized by attacks of burning pain in the hands and feet with local congestion and increased skin temperature. We report a case of erythromelalgia, with transient hypertension and elevated urinary catecholamines successfully treated by hypnotherapy. Such an association has not to our knowledge been previously reported in English language publications.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1561190      PMCID: PMC2399324          DOI: 10.1136/pgmj.68.795.44

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  ERYTHERMALGIA. REVIEW OF 51 CASES.

Authors:  R R BABB; D ALARCON-SEGOVIA; J F FAIRBAIRN
Journal:  Circulation       Date:  1964-01       Impact factor: 29.690

2.  Three types of erythromelalgia.

Authors:  J P Drenth; J J Michiels
Journal:  BMJ       Date:  1990-09-08

3.  [Erythromelalgia, arterial hypertension and increased excretion of urinary catecholamines].

Authors:  P Blanchard; B Grenier; S Marchand; M M Ruchoux
Journal:  Arch Fr Pediatr       Date:  1987-11

4.  Autonomic innervation of the skin in primary erythermalgia.

Authors:  H Uno; F Parker
Journal:  Arch Dermatol       Date:  1983-01
  4 in total
  4 in total

1.  Erythromelalgia.

Authors:  Mark D. P. Davis; Thom Rooke
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

2.  Erythromelalgia.

Authors:  Mark D P Davis; Thom Rooke
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

3.  Acute secondary erythermalgia and hypertension in children. Erythermalgia Multidisciplinary Study Group.

Authors:  J P Drenth; J J Michiels; S Ozsoylu
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

Review 4.  Current pain management strategies for patients with erythromelalgia: a critical review.

Authors:  See Wan Tham; Marian Giles
Journal:  J Pain Res       Date:  2018-08-30       Impact factor: 3.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.